Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||||||||||||||||||||||
net income | -12,804,000 | -25,684,000 | -14,855,000 | -488,000 | 48,332,000 | 129,928,000 | -30,766,000 | 111,248,000 | 278,777,000 | -52,516,000 | -292,344,000 | -37,245,000 | -120,987,000 | -68,081,000 | -343,684,000 | -42,865,000 | -51,364,000 | -95,083,000 | -627,599,000 | -306,130,000 | -361,230,000 | -2,718,993,000 | -404,057,000 | 931,728,000 | -565,842,000 | -484,646,000 | -30,155,000 | -413,082,000 | -13,946,000 | -41,848,000 | -26,299,000 | -294,584,000 | 72,589,000 | 105,192,000 | 52,190,000 |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||
unrealized carried interest (allocation) reversal | 63,582,000 | ||||||||||||||||||||||||||||||||||
unrealized principal investment (income) loss | -24,681,000 | ||||||||||||||||||||||||||||||||||
equity-based compensation | 8,827,000 | 10,704,000 | 7,155,000 | -71,000 | 8,757,000 | 17,350,000 | 8,680,000 | 10,052,000 | 15,010,000 | 25,965,000 | 16,612,000 | 7,591,000 | 19,055,000 | 9,345,000 | 18,719,000 | 19,415,000 | 9,040,000 | 11,642,000 | 19,319,000 | 8,544,000 | 7,744,000 | 10,422,000 | 8,249,000 | 14,522,000 | 10,122,000 | 8,266,000 | 6,663,000 | 11,753,000 | 8,557,000 | 9,397,000 | 12,169,000 | 43,125,000 | 41,206,000 | 37,914,000 | 32,184,000 |
amortization of deferred financing costs and debt discount and premium | 406,000 | 1,106,000 | 524,000 | 524,000 | 524,000 | 584,000 | 664,000 | 1,364,000 | 2,036,000 | 5,537,000 | 12,182,000 | 3,467,000 | 3,495,000 | 3,169,000 | 96,279,000 | 8,635,000 | 5,123,000 | 7,642,000 | 43,729,000 | -15,459,000 | 5,434,000 | 10,367,000 | 15,260,000 | 41,758,000 | 16,201,000 | 25,984,000 | 19,594,000 | 20,325,000 | 21,221,000 | 25,291,000 | 22,802,000 | 23,945,000 | 18,172,000 | 20,866,000 | 20,736,000 |
depreciation and amortization | 7,130,000 | 8,585,000 | 7,226,000 | 8,215,000 | 8,227,000 | 8,097,000 | 9,167,000 | 66,415,000 | 128,000,000 | 149,562,000 | 141,574,000 | 147,398,000 | 145,594,000 | 155,352,000 | 130,906,000 | 138,042,000 | 138,095,000 | 170,113,000 | 190,305,000 | 138,819,000 | 166,425,000 | 135,547,000 | 137,491,000 | 119,376,000 | 171,347,000 | 154,742,000 | 150,797,000 | 144,495,000 | 145,310,000 | 137,896,000 | 144,705,000 | 164,554,000 | 162,694,000 | 153,111,000 | 137,420,000 |
deferred income tax (benefit) expense | -947,000 | -866,000 | -295,000 | -1,552,000 | -999,000 | 125,000 | -734,000 | 799,000 | -3,337,000 | 1,588,000 | 881,000 | ||||||||||||||||||||||||
other (gain) loss | -5,129,000 | -12,337,000 | 623,000 | -1,080,000 | -48,362,000 | -7,176,000 | 19,267,000 | 8,791,000 | 44,547,000 | 88,223,000 | 49,077,000 | 82,025,000 | -29,677,000 | ||||||||||||||||||||||
other adjustments | 301,000 | -474,000 | -287,000 | -262,000 | 16,000 | -229,000 | 32,000 | -498,000 | 154,000 | 324,000 | 182,000 | -503,000 | 269,000 | 223,000 | -986,000 | -2,589,000 | -1,819,000 | -2,500,000 | -576,000 | -7,365,000 | -1,069,000 | -1,767,000 | -1,747,000 | -3,215,000 | -687,000 | -2,173,000 | -2,036,000 | -1,794,000 | -1,704,000 | -3,163,000 | 4,082,000 | -1,179,000 | 5,019,000 | 332,000 | -78,000 |
increase in other assets and due from affiliates | 1,159,000 | 11,263,000 | 11,997,000 | -23,893,000 | 13,804,000 | -6,453,000 | 1,940,000 | -10,282,000 | -19,851,000 | -411,000 | 23,486,000 | 25,793,000 | -2,932,000 | 16,697,000 | -4,186,000 | 19,523,000 | -34,902,000 | -6,406,000 | -7,450,000 | -136,000 | -12,767,000 | -3,584,000 | 9,764,000 | 2,675,000 | -33,820,000 | -18,742,000 | |||||||||
increase in other liabilities and due to affiliates | 18,655,000 | 27,482,000 | -25,547,000 | -134,605,000 | -2,893,000 | 176,239,000 | -43,269,000 | ||||||||||||||||||||||||||||
net cash generated by (used in) operating activities | 56,499,000 | 76,973,000 | 50,298,000 | 28,704,000 | 35,901,000 | ||||||||||||||||||||||||||||||
cash flows from investing activities | |||||||||||||||||||||||||||||||||||
contributions to and acquisition of equity investments | -84,340,000 | -163,237,000 | -26,529,000 | -53,860,000 | -41,483,000 | -15,718,000 | -59,129,000 | -114,406,000 | -64,480,000 | -264,705,000 | -140,998,000 | -124,996,000 | -146,513,000 | -83,486,000 | -215,040,000 | -138,028,000 | -114,595,000 | -179,222,000 | -117,776,000 | -141,457,000 | -129,166,000 | -33,088,000 | -126,837,000 | -25,200,000 | -105,637,000 | -15,185,000 | -101,335,000 | ||||||||
return of capital from equity and debt investments | 9,091,000 | 38,984,000 | 29,658,000 | 22,407,000 | |||||||||||||||||||||||||||||||
proceeds from sale of equity investments | 46,577,000 | 38,895,000 | 14,651,000 | 27,363,000 | 46,995,000 | 8,569,000 | 23,471,000 | 58,996,000 | 41,478,000 | 286,955,000 | 308,254,000 | 38,504,000 | 244,270,000 | 45,039,000 | 194,524,000 | 250,430,000 | 152,373,000 | 70,713,000 | 90,509,000 | 32,978,000 | 13,413,000 | 10,430,000 | 231,078,000 | 12,999,000 | 124,495,000 | 8,658,000 | 19,505,000 | ||||||||
repayment of loans receivable | 0 | ||||||||||||||||||||||||||||||||||
purchase of fixed assets | -363,000 | -622,000 | -306,000 | -283,000 | 0 | -250,000 | -3,055,000 | ||||||||||||||||||||||||||||
cash recognized in consolidation of sponsored fund | |||||||||||||||||||||||||||||||||||
cash derecognized in deconsolidation of sponsored funds | 0 | ||||||||||||||||||||||||||||||||||
net cash generated by (used in) investing activities | -29,005,000 | -85,980,000 | 17,474,000 | -4,373,000 | 10,380,000 | ||||||||||||||||||||||||||||||
cash flows from financing activities | |||||||||||||||||||||||||||||||||||
dividends paid to preferred stockholders | -14,661,000 | -14,660,000 | -14,660,000 | -14,660,000 | -14,661,000 | -14,660,000 | -14,660,000 | -14,660,000 | -14,660,000 | -14,675,000 | -14,766,000 | -14,766,000 | -16,111,000 | -15,758,000 | -15,760,000 | -17,279,000 | -19,073,000 | -18,516,000 | -18,516,000 | -18,516,000 | -18,516,000 | -18,516,000 | -23,785,000 | -27,137,000 | -27,137,000 | -27,137,000 | -27,137,000 | -27,137,000 | -29,357,000 | -31,387,000 | -32,821,000 | -30,228,000 | -29,034,000 | -37,769,000 | -33,151,000 |
dividends paid to common stockholders | -1,811,000 | -1,766,000 | -1,744,000 | -1,738,000 | -1,737,000 | -1,662,000 | -1,634,000 | -1,639,000 | -1,624,000 | -1,615,000 | -1,599,000 | 0 | 0 | -52,853,000 | -53,657,000 | -53,659,000 | -53,654,000 | -53,410,000 | -53,426,000 | -54,015,000 | -53,952,000 | -55,852,000 | -146,700,000 | -148,260,000 | -149,022,000 | -134,150,000 | -50,724,000 | ||||||||
repayment or redemption of senior notes | 0 | 0 | |||||||||||||||||||||||||||||||||
shares canceled for tax withholdings on vested equity awards | -776,000 | -400,000 | -5,037,000 | -395,000 | -929,000 | -213,000 | -8,303,000 | -504,000 | -7,959,000 | -5,354,000 | -4,863,000 | -227,000 | -1,535,000 | -5,067,000 | -11,410,000 | -790,000 | -1,673,000 | ||||||||||||||||||
contributions from noncontrolling interests | 10,332,000 | 14,228,000 | 4,197,000 | 3,887,000 | 4,792,000 | 10,700,000 | 9,609,000 | 20,950,000 | 26,907,000 | 38,540,000 | 29,684,000 | 552,712,000 | 1,503,954,000 | 215,790,000 | 353,156,000 | 29,085,000 | 24,292,000 | 54,915,000 | 123,852,000 | 552,384,000 | 1,127,687,000 | 139,096,000 | 87,083,000 | 21,641,000 | 110,129,000 | 199,903,000 | 247,033,000 | 312,065,000 | 302,442,000 | 297,111,000 | 108,270,000 | 86,313,000 | 185,311,000 | 225,021,000 | 676,787,000 |
distributions to and redemption of noncontrolling interests | -652,000 | -591,000 | -4,631,000 | -129,000 | |||||||||||||||||||||||||||||||
payment of contingent consideration to wafra | 0 | 0 | 0 | -17,500,000 | 0 | 0 | 0 | -90,000,000 | |||||||||||||||||||||||||||
net cash generated by (used in) financing activities | -7,568,000 | -3,189,000 | -21,875,000 | -13,035,000 | -15,886,000 | ||||||||||||||||||||||||||||||
effect of foreign exchange on cash, cash equivalents and restricted cash | -997,000 | 3,111,000 | 1,911,000 | -3,474,000 | |||||||||||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash | 18,929,000 | -9,085,000 | 47,808,000 | 7,822,000 | 32,560,000 | 13,775,000 | -98,109,000 | -188,420,000 | -42,900,000 | -242,644,000 | -212,525,000 | 266,349,000 | 324,554,000 | -778,184,000 | -542,225,000 | 337,316,000 | 254,806,000 | 139,732,000 | 71,383,000 | 108,484,000 | -314,000 | -48,216,000 | -58,466,000 | -454,194,000 | |||||||||||
cash, cash equivalents and restricted cash—beginning of period | 0 | 0 | 306,298,000 | 0 | 0 | 0 | 350,250,000 | 0 | 0 | 0 | 1,036,739,000 | ||||||||||||||||||||||||
cash, cash equivalents and restricted cash—end of period | 18,929,000 | -9,085,000 | 354,106,000 | 7,822,000 | 32,560,000 | 13,775,000 | 252,141,000 | -188,420,000 | -42,900,000 | -242,644,000 | 824,214,000 | ||||||||||||||||||||||||
cash derecognized in deconsolidation of sponsored funds and investment entities | |||||||||||||||||||||||||||||||||||
unrealized carried interest allocation | 34,026,000 | 177,986,000 | 15,799,000 | -288,126,000 | 8,478,000 | -169,210,000 | |||||||||||||||||||||||||||||
unrealized principal investment income | 29,731,000 | 3,930,000 | -7,304,000 | -7,813,000 | -468,000 | -93,534,000 | |||||||||||||||||||||||||||||
investment deposits | 766,000 | -1,932,000 | -539,000 | 4,035,000 | -5,704,000 | 50,366,000 | 816,000 | -37,185,000 | -13,367,000 | -21,075,000 | 0 | -3,510,000 | -1,523,000 | -3,034,000 | -3,593,000 | -1,718,000 | 7,043,000 | -5,959,000 | -14,294,000 | 61,259,000 | -81,349,000 | -11,841,000 | -2,383,000 | 2,454,000 | 44,196,000 | -37,987,000 | -9,143,000 | ||||||||
loss on debt extinguishment | |||||||||||||||||||||||||||||||||||
other equity method (earnings) losses | 1,905,000 | -20,000 | 2,694,000 | 10,609,000 | |||||||||||||||||||||||||||||||
distributions of income from equity investments | |||||||||||||||||||||||||||||||||||
paid-in-kind interest added to loan principal | -404,000 | 0 | -10,188,000 | -8,732,000 | -7,572,000 | ||||||||||||||||||||||||||||||
straight-line rent income | -4,266,000 | -2,222,000 | -1,854,000 | -1,944,000 | -7,071,000 | -13,153,000 | -734,000 | -4,530,000 | 780,000 | -2,643,000 | -6,818,000 | 18,800,000 | |||||||||||||||||||||||
amortization of above- and below-market lease values | 448,000 | 352,000 | 619,000 | 245,000 | 266,000 | 83,000 | -9,000 | -132,000 | -109,000 | -159,000 | -788,000 | 6,098,000 | -943,000 | -1,439,000 | -558,000 | -3,506,000 | -9,831,000 | -3,251,000 | -3,088,000 | -3,643,000 | -2,114,000 | -3,245,000 | 422,000 | -1,925,000 | -8,343,000 | -1,379,000 | -3,619,000 | -1,978,000 | |||||||
impairment of real estate and intangible assets | 12,761,000 | 8,519,000 | |||||||||||||||||||||||||||||||||
acquisition of loans receivable and debt securities | 0 | -7,866,000 | -55,342,000 | -101,607,000 | -79,045,000 | -43,482,000 | -15,274,000 | -9,697,000 | 0 | 0 | -320,000 | -451,000 | |||||||||||||||||||||||
net disbursements on originated loans | 0 | 0 | -10,411,000 | -205,507,000 | 0 | -15,286,000 | -14,355,000 | -3,631,000 | -39,234,000 | -2,762,000 | -114,182,000 | -63,812,000 | -74,144,000 | -54,401,000 | -18,523,000 | -21,892,000 | -42,953,000 | -186,456,000 | -76,970,000 | -11,573,000 | -109,094,000 | -111,679,000 | -62,438,000 | -109,579,000 | |||||||||||
proceeds from sales of loans receivable and debt securities | 0 | 126,644,000 | 0 | 37,329,000 | 15,547,000 | 13,373,000 | |||||||||||||||||||||||||||||
proceeds from paydown and maturity of debt securities | 7,000 | 0 | 0 | 566,000 | 717,000 | 362,000 | 1,242,000 | 1,307,000 | 1,549,000 | 1,623,000 | 2,025,000 | 3,142,000 | 2,700,000 | 3,338,000 | |||||||||||||||||||||
acquisition of infrabridge, net of cash acquired | 0 | 0 | -1,102,000 | -313,164,000 | |||||||||||||||||||||||||||||||
net receipt (payment) on settlement of derivatives | 0 | 0 | |||||||||||||||||||||||||||||||||
acquisition of and additions to real estate, related intangibles and leasing commissions | -40,361,000 | -102,136,000 | -348,055,000 | -162,918,000 | -239,306,000 | -172,165,000 | -907,398,000 | -822,368,000 | -220,206,000 | -451,211,000 | -82,920,000 | -74,024,000 | -1,280,386,000 | -1,146,990,000 | -53,684,000 | -78,283,000 | -120,278,000 | -207,580,000 | -322,697,000 | -1,267,762,000 | -601,593,000 | -205,302,000 | -306,180,000 | -236,392,000 | |||||||||||
proceeds from databank recapitalization | |||||||||||||||||||||||||||||||||||
proceeds from sales of real estate investment holding entities | |||||||||||||||||||||||||||||||||||
other investing activities | 0 | 106,000 | 0 | -875,000 | 0 | -749,000 | -6,163,000 | 5,593,000 | 3,423,000 | -1,742,000 | 5,457,000 | -1,727,000 | 4,900,000 | 14,176,000 | 216,000 | 3,258,000 | -2,477,000 | -582,000 | 11,017,000 | -2,107,000 | 21,000 | -2,271,000 | |||||||||||||
borrowings on corporate debt | |||||||||||||||||||||||||||||||||||
repurchases of preferred stock | 0 | ||||||||||||||||||||||||||||||||||
repurchases of common stock | -46,998,000 | ||||||||||||||||||||||||||||||||||
acquisition of noncontrolling interest | 0 | 0 | 0 | -32,076,000 | |||||||||||||||||||||||||||||||
borrowings from investment level debt | 0 | ||||||||||||||||||||||||||||||||||
repayments of investment level debt | -5,323,000 | ||||||||||||||||||||||||||||||||||
payment of deferred financing costs and prepayment penalties on investment level debt | 0 | -17,000 | -8,530,000 | -29,482,000 | |||||||||||||||||||||||||||||||
return of capital from equity method investments | 12,651,000 | 15,979,000 | 13,466,000 | 10,120,000 | 3,384,000 | 52,259,000 | 688,000 | 32,908,000 | 13,823,000 | 11,829,000 | 48,426,000 | 26,746,000 | 12,780,000 | 2,253,000 | 170,980,000 | 1,840,000 | 92,726,000 | 29,386,000 | 47,661,000 | 57,960,000 | 100,238,000 | 18,310,000 | |||||||||||||
repayments of loans receivable | 0 | 0 | 0 | 4,751,000 | 3,360,000 | 15,845,000 | -6,409,000 | 128,336,000 | 354,888,000 | 8,798,000 | 96,463,000 | 73,377,000 | 8,858,000 | 49,133,000 | 1,490,000 | 1,592,000 | 137,689,000 | 89,199,000 | 30,891,000 | 55,035,000 | 17,349,000 | 40,085,000 | 310,821,000 | 302,951,000 | 126,725,000 | 90,577,000 | |||||||||
distributions to and redemptions of noncontrolling interests | -2,614,000 | -15,983,000 | -19,268,000 | -16,935,000 | -83,760,000 | -43,839,000 | -424,477,000 | -1,234,415,000 | -39,739,000 | -32,857,000 | -98,990,000 | -63,523,000 | -129,471,000 | -68,320,000 | -2,404,216,000 | -93,803,000 | -220,077,000 | -129,734,000 | -147,574,000 | -128,663,000 | -141,201,000 | -101,426,000 | |||||||||||||
effect of exchange rates on cash, cash equivalents and restricted cash | -43,000 | -661,000 | 1,439,000 | -747,000 | 700,000 | -626,000 | 574,000 | -624,000 | -1,764,000 | -651,000 | -3,415,000 | -5,715,000 | 2,255,000 | 4,050,000 | 3,870,000 | 5,968,000 | 1,182,000 | -3,650,000 | 8,197,000 | -6,814,000 | 1,561,000 | -1,196,000 | -4,646,000 | -1,972,000 | -9,752,000 | 4,832,000 | |||||||||
net cash from operating activities | -27,009,000 | 41,557,000 | 99,875,000 | 72,020,000 | 20,185,000 | 67,809,000 | 127,470,000 | 66,046,000 | 1,257,000 | 66,825,000 | 76,516,000 | 128,833,000 | -23,937,000 | 7,000 | 47,574,000 | 101,981,000 | -59,669,000 | -63,722,000 | 95,439,000 | 72,515,000 | 66,636,000 | 113,666,000 | 181,919,000 | 111,428,000 | 99,952,000 | 164,124,000 | 200,556,000 | 162,017,000 | 22,920,000 | ||||||
net cash from investing activities | -21,968,000 | -210,972,000 | -196,518,000 | -312,684,000 | -258,870,000 | 15,953,000 | 216,281,000 | -1,043,493,000 | -1,102,149,000 | 60,867,000 | -322,898,000 | 416,497,000 | -7,901,000 | -950,057,000 | -1,096,488,000 | -52,356,000 | 166,921,000 | 5,136,605,000 | -79,477,000 | 66,761,000 | -924,951,000 | -350,195,000 | 18,625,000 | 203,599,000 | -140,242,000 | 723,832,000 | 353,543,000 | -239,698,000 | 493,865,000 | ||||||
net cash from financing activities | -48,471,000 | -20,444,000 | 54,490,000 | -2,680,000 | 26,786,000 | 182,013,000 | -18,573,000 | 201,027,000 | 559,318,000 | 213,039,000 | 506,903,000 | -407,853,000 | 99,171,000 | 1,009,802,000 | 692,715,000 | -334,372,000 | 4,882,000 | -4,385,459,000 | 26,138,000 | -96,940,000 | 676,675,000 | 240,861,000 | -246,788,000 | -363,741,000 | -418,736,000 | -868,128,000 | -264,612,000 | 32,918,000 | -246,683,000 | ||||||
amortization of discount and net origination fees on loans receivable and debt securities | -1,064,000 | -1,131,000 | -3,365,000 | -594,000 | -4,387,000 | -5,466,000 | -4,323,000 | -5,426,000 | -2,010,000 | -6,837,000 | -6,352,000 | -7,995,000 | |||||||||||||||||||||||
distributions of income from equity method investments | 49,000 | 50,000 | 3,120,000 | 557,000 | 30,884,000 | -18,000 | 1,803,000 | 749,000 | 520,000 | 10,167,000 | 3,692,000 | 68,257,000 | 20,496,000 | 65,198,000 | 23,475,000 | 27,821,000 | 26,923,000 | 22,529,000 | 22,542,000 | 11,617,000 | 23,307,000 | 21,674,000 | 16,552,000 | 14,338,000 | 19,633,000 | ||||||||||
allowance for doubtful accounts | -346,000 | 3,418,000 | 17,000 | 205,000 | -1,408,000 | 4,775,000 | 3,476,000 | 404,000 | 2,572,000 | -198,000 | 30,000 | 4,389,000 | 1,659,000 | 3,097,000 | |||||||||||||||||||||
gain on sales of real estate | -197,000 | -514,000 | -2,968,000 | -45,750,000 | -26,661,000 | -12,248,000 | 4,919,000 | -7,932,000 | -1,448,984,000 | -12,899,000 | -6,624,000 | -52,301,000 | -70,965,000 | -35,120,000 | -42,702,000 | -18,444,000 | -40,669,000 | ||||||||||||||||||
(gain) loss on debt extinguishment | |||||||||||||||||||||||||||||||||||
increase in accrued and other liabilities and due to affiliates | 125,739,000 | 115,399,000 | 37,074,000 | -85,149,000 | 71,421,000 | 80,356,000 | 52,339,000 | -55,136,000 | 25,352,000 | 55,718,000 | -13,232,000 | -7,460,000 | 33,527,000 | -19,053,000 | -30,056,000 | ||||||||||||||||||||
proceeds from sale of fixed assets | |||||||||||||||||||||||||||||||||||
cash and restricted cash derecognized in deconsolidation of investment entities | |||||||||||||||||||||||||||||||||||
proceeds from databank recapitalization, net of carried interest distribution | 0 | ||||||||||||||||||||||||||||||||||
repayments of corporate debt, including senior notes | 0 | ||||||||||||||||||||||||||||||||||
other gain | -255,566,000 | 9,981,000 | 142,644,000 | -63,976,000 | -22,446,000 | ||||||||||||||||||||||||||||||
cash and restricted cash assumed by buyer in sales of real estate investment holding entities | 0 | 0 | -189,453,000 | ||||||||||||||||||||||||||||||||
cash and restricted cash derecognized in databank deconsolidation | |||||||||||||||||||||||||||||||||||
carried interest (allocation) reversal | -79,254,000 | 54,756,000 | |||||||||||||||||||||||||||||||||
principal investment (income) loss | -30,409,000 | -3,562,000 | |||||||||||||||||||||||||||||||||
impairment of real estate and related intangibles and right-of-use ("rou") asset | |||||||||||||||||||||||||||||||||||
loss on extinguishment of debt | |||||||||||||||||||||||||||||||||||
cash transferred to buyer in sale of real estate, net of proceeds received | |||||||||||||||||||||||||||||||||||
repayments of corporate debt, including repurchase of senior notes | |||||||||||||||||||||||||||||||||||
borrowings from investment-level debt | 375,900,000 | 1,241,890,000 | |||||||||||||||||||||||||||||||||
repayments of investment-level debt | -98,428,000 | -1,060,239,000 | |||||||||||||||||||||||||||||||||
redemptions/repurchases of preferred stock | 0 | ||||||||||||||||||||||||||||||||||
paid-in-kind interest added to loan principal, net of interest received | -544,000 | -2,257,000 | -2,110,000 | -1,633,000 | -1,144,000 | -94,000 | 14,350,000 | -1,591,000 | -4,267,000 | -1,542,000 | -6,022,000 | -9,616,000 | -21,218,000 | -19,855,000 | -17,581,000 | -15,248,000 | -9,780,000 | -12,879,000 | -8,914,000 | -10,129,000 | -6,486,000 | ||||||||||||||
impairment of real estate and related intangibles and right-of-use asset | 0 | 0 | 12,183,000 | 23,802,000 | -40,733,000 | ||||||||||||||||||||||||||||||
proceeds from sales of real estate, net of property level cash transferred to buyer | |||||||||||||||||||||||||||||||||||
net receipts on settlement of derivatives | 3,401,000 | -4,600,000 | 0 | 0 | 1,210,000 | 15,913,000 | 0 | 23,870,000 | 3,227,000 | ||||||||||||||||||||||||||
equity method (earnings) losses | -191,259,000 | -49,625,000 | -82,068,000 | ||||||||||||||||||||||||||||||||
goodwill impairment | 0 | 0 | 515,000,000 | 79,000,000 | 401,000,000 | ||||||||||||||||||||||||||||||
unrealized settlement loss | 0 | 0 | 0 | 3,890,000 | |||||||||||||||||||||||||||||||
loss on extinguishment of exchangeable notes | 0 | 0 | 0 | 133,173,000 | |||||||||||||||||||||||||||||||
other loss | -7,042,000 | -34,748,000 | 46,703,000 | 17,332,000 | -42,677,000 | -99,665,000 | -11,088,000 | 213,661,000 | 13,094,000 | 173,432,000 | 9,279,000 | 23,729,000 | 14,912,000 | ||||||||||||||||||||||
proceeds from sales of loans receivable and debt securities, including transfers of warehoused loans | 40,229,000 | ||||||||||||||||||||||||||||||||||
proceeds from sales of real estate, including transfers of warehoused assets, net of property level cash transferred to buyer | |||||||||||||||||||||||||||||||||||
proceeds from sale of corporate fixed assets | 0 | ||||||||||||||||||||||||||||||||||
acquisition of dbh, net of cash acquired, and payment of deferred purchase price | 0 | ||||||||||||||||||||||||||||||||||
debt borrowings | |||||||||||||||||||||||||||||||||||
debt repayments | |||||||||||||||||||||||||||||||||||
payment of deferred financing costs | 19,000 | -121,000 | -11,587,000 | -6,999,000 | -17,769,000 | -11,329,000 | -486,000 | -18,543,000 | -46,220,000 | -6,079,000 | -2,311,000 | -140,000 | -25,660,000 | -1,757,000 | -38,085,000 | -16,700,000 | -8,792,000 | -11,662,000 | -3,064,000 | -5,112,000 | -31,630,000 | -9,875,000 | -45,125,000 | -9,439,000 | |||||||||||
contribution from wafra | 0 | ||||||||||||||||||||||||||||||||||
other financing activities | -8,639,000 | 1,351,000 | -1,717,000 | -1,138,000 | -2,244,000 | 162,000 | 5,354,000 | -7,026,000 | -906,000 | -4,670,000 | |||||||||||||||||||||||||
deferred income tax benefit | 851,000 | -6,605,000 | -9,040,000 | 30,814,000 | -34,480,000 | -9,138,000 | -7,824,000 | -840,000 | -18,470,000 | -5,779,000 | -3,716,000 | -41,465,000 | |||||||||||||||||||||||
proceeds from sales of real estate | 0 | 0 | 96,660,000 | 80,053,000 | 29,706,000 | 268,922,000 | 64,808,000 | 172,758,000 | 88,423,000 | 43,276,000 | 126,741,000 | 5,448,908,000 | 216,588,000 | 147,990,000 | 294,667,000 | ||||||||||||||||||||
repayment or repurchase of senior notes | 0 | 0 | -14,237,000 | ||||||||||||||||||||||||||||||||
borrowings from corporate credit facility and securitized financing facility | 0 | ||||||||||||||||||||||||||||||||||
repayment of borrowings from corporate credit facility and securitized financing facility | |||||||||||||||||||||||||||||||||||
borrowings from secured debt | 324,500,000 | 363,582,000 | 326,500,000 | 943,813,000 | 452,774,000 | 13,598,000 | 684,537,000 | 1,983,426,000 | 24,485,000 | 870,000 | 8,052,000 | 1,395,037,000 | 243,003,000 | 1,856,633,000 | 1,169,777,000 | 611,344,000 | 747,269,000 | 341,858,000 | 90,550,000 | 1,376,545,000 | |||||||||||||||
repayment of secured debt | -464,058,000 | -1,558,000 | -3,894,000 | ||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of period | 0 | 0 | 1,766,245,000 | 0 | 0 | 0 | 963,008,000 | 0 | 0 | 0 | 1,424,698,000 | 0 | 0 | 0 | 832,730,000 | 0 | 0 | 0 | 1,393,920,000 | ||||||||||||||||
cash, cash equivalents and restricted cash, end of period | 324,554,000 | -778,184,000 | 1,224,020,000 | 337,316,000 | 254,806,000 | 139,732,000 | 1,034,391,000 | 63,622,000 | -350,231,000 | -283,565,000 | 1,533,182,000 | 695,621,000 | 35,286,000 | 43,897,000 | 649,894,000 | -314,000 | -48,216,000 | -58,466,000 | 939,726,000 | ||||||||||||||||
equity method (gains) losses | -152,903,000 | -116,000 | |||||||||||||||||||||||||||||||||
net (payments) receipts on settlement of derivatives | |||||||||||||||||||||||||||||||||||
repayment of borrowings from corporate credit facility securitized financing facility | |||||||||||||||||||||||||||||||||||
distributions to and redemptions by noncontrolling interests | -35,962,000 | -119,293,000 | |||||||||||||||||||||||||||||||||
benefit from loan losses | 33,000 | 17,233,000 | 15,003,000 | 3,611,000 | 15,901,000 | 7,825,000 | 13,933,000 | 5,375,000 | 6,834,000 | 5,116,000 | 1,067,000 | 6,724,000 | |||||||||||||||||||||||
settlement of forward starting interest rate swap | -141,225,000 | ||||||||||||||||||||||||||||||||||
loss on induced conversion of exchangeable debt | |||||||||||||||||||||||||||||||||||
cash receipts in excess of accretion on purchased credit-impaired loans | 12,242,000 | 8,741,000 | 1,538,000 | 8,607,000 | 23,772,000 | 91,302,000 | 22,692,000 | 21,463,000 | |||||||||||||||||||||||||||
cash and restricted cash assumed by buyer upon sale of hotel portfolio in receivership | 0 | ||||||||||||||||||||||||||||||||||
acquisition of databank, net of cash acquired | |||||||||||||||||||||||||||||||||||
repurchase of common stock | 0 | 0 | 0 | -24,749,000 | 0 | 0 | 0 | -10,734,000 | -24,114,000 | 0 | -108,755,000 | -210,274,000 | -75,565,000 | -56,627,000 | -111,976,000 | -56,009,000 | |||||||||||||||||||
proceeds from issuance of exchangeable senior notes | 0 | ||||||||||||||||||||||||||||||||||
repayment of senior notes | 0 | 0 | |||||||||||||||||||||||||||||||||
repayment of borrowings from corporate credit facility | 0 | 0 | -400,000,000 | -254,200,000 | -423,000,000 | 0 | -181,000,000 | -371,000,000 | -183,000,000 | -211,000,000 | -192,000,000 | -130,000,000 | -880,600,000 | ||||||||||||||||||||||
repayments of secured debt | -540,728,000 | -49,644,000 | -453,446,000 | -600,082,000 | -1,360,851,000 | -141,442,000 | -70,030,000 | -111,678,000 | -3,098,400,000 | -250,800,000 | -1,898,050,000 | -498,259,000 | -416,519,000 | -870,293,000 | -559,707,000 | -139,471,000 | -1,432,530,000 | ||||||||||||||||||
redemption of preferred stock | -64,000,000 | 0 | 0 | 0 | -402,855,000 | 0 | -322,118,000 | 0 | |||||||||||||||||||||||||||
equity method losses | 60,196,000 | -93,271,000 | 111,519,000 | 129,218,000 | 56,916,000 | ||||||||||||||||||||||||||||||
payment of cash collateral on derivative | 2,000,000 | 3,870,000 | -6,641,000 | ||||||||||||||||||||||||||||||||
payment of offering costs | |||||||||||||||||||||||||||||||||||
impairment of real estate and related intangibles and right-of-use assets | 242,587,000 | 123,760,000 | 40,344,000 | 151,961,000 | 1,486,557,000 | 308,268,000 | |||||||||||||||||||||||||||||
proceeds from sale of non-real estate fixed assets | 0 | 14,946,000 | |||||||||||||||||||||||||||||||||
borrowings from corporate credit facility | 0 | 0 | 0 | 600,000,000 | 70,000,000 | 522,200,000 | 0 | 181,000,000 | 271,000,000 | 233,000,000 | 261,000,000 | 121,000,000 | 201,000,000 | 458,000,000 | |||||||||||||||||||||
decrease (increase) in other assets and due from affiliates | -31,721,000 | 4,048,000 | -1,037,000 | ||||||||||||||||||||||||||||||||
repayment of convertible senior notes | -31,502,000 | ||||||||||||||||||||||||||||||||||
shares canceled for tax withholdings on vested stock awards | -7,718,000 | -1,011,000 | -512,000 | -1,157,000 | -5,069,000 | -226,000 | -394,000 | 0 | -3,007,000 | -2,153,000 | 0 | -298,000 | -31,752,000 | ||||||||||||||||||||||
cash and restricted cash contributed to clnc | |||||||||||||||||||||||||||||||||||
proceeds from sale of equity interests in securitization trusts, net of cash and restricted cash deconsolidated | 0 | 0 | |||||||||||||||||||||||||||||||||
net receipts (payments) on settlement of derivatives | 2,528,000 | ||||||||||||||||||||||||||||||||||
repurchase of convertible senior notes | 0 | ||||||||||||||||||||||||||||||||||
redemption of op units for cash | 0 | -2,734,000 | |||||||||||||||||||||||||||||||||
straight-line rents | -6,535,000 | -5,312,000 | -2,069,000 | -7,478,000 | -761,000 | -6,973,000 | -5,529,000 | -7,207,000 | -7,369,000 | -7,001,000 | -7,753,000 | -7,031,000 | -9,514,000 | -8,213,000 | -7,906,000 | ||||||||||||||||||||
deferred income tax expense | -11,179,000 | ||||||||||||||||||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -350,231,000 | 35,286,000 | 43,897,000 | -182,836,000 | |||||||||||||||||||||||||||||||
decrease in accrued and other liabilities and due to affiliates | 27,220,000 | -81,407,000 | 20,227,000 | -37,205,000 | 7,864,000 | 20,584,000 | |||||||||||||||||||||||||||||
payment of deferred purchase price on dbh acquisition | |||||||||||||||||||||||||||||||||||
equity method earnings | -97,291,000 | -38,487,000 | |||||||||||||||||||||||||||||||||
impairment of real estate and intangibles | 70,227,000 | 177,899,000 | 84,695,000 | 25,622,000 | 288,494,000 | 76,497,000 | |||||||||||||||||||||||||||||
change in fair value of contingent consideration—internalization | 0 | 0 | 8,750,000 | -10,480,000 | -6,260,000 | ||||||||||||||||||||||||||||||
cash and restricted cash assumed in merger, net of payments for merger-related liabilities | |||||||||||||||||||||||||||||||||||
proceeds from syndication of investment, net of cash and restricted cash deconsolidated | |||||||||||||||||||||||||||||||||||
proceeds from sale of townsend, net of cash assumed by buyer | |||||||||||||||||||||||||||||||||||
acquisition of cpi, net of cash and restricted cash acquired | |||||||||||||||||||||||||||||||||||
acquisition of thl hotel portfolio, net of cash and restricted cash acquired | |||||||||||||||||||||||||||||||||||
return of borrower escrow deposits | |||||||||||||||||||||||||||||||||||
acquisition of dbh | |||||||||||||||||||||||||||||||||||
proceeds from issuance of preferred stock | -30,000 | 304,670,000 | |||||||||||||||||||||||||||||||||
repurchase of exchangeable senior notes | 0 | -3,500,000 | |||||||||||||||||||||||||||||||||
cash and restricted cash contributed to colony credit | 0 | 0 | |||||||||||||||||||||||||||||||||
acquisition of dbh, net of cash acquired | |||||||||||||||||||||||||||||||||||
payments of cash collateral on derivative, net of cash received | |||||||||||||||||||||||||||||||||||
net receipts (payments) on settlement of derivative instruments | 10,185,000 | 19,608,000 | |||||||||||||||||||||||||||||||||
receipts (payments) of cash collateral on derivative | -31,054,000 | ||||||||||||||||||||||||||||||||||
payment of cash collateral on derivatives | -10,900,000 | ||||||||||||||||||||||||||||||||||
accretion in excess of cash receipts on purchased credit-impaired loan | |||||||||||||||||||||||||||||||||||
contributions to investments in unconsolidated ventures | -337,987,000 | -20,978,000 | -98,518,000 | -90,680,000 | -158,115,000 | -153,149,000 | -196,130,000 | -15,541,000 | |||||||||||||||||||||||||||
acquisition of loans receivable and securities | -4,591,000 | -17,179,000 | -8,744,000 | -73,733,000 | |||||||||||||||||||||||||||||||
proceeds from sales of loans receivable and securities | 66,893,000 | 32,981,000 | 30,516,000 | 95,217,000 | |||||||||||||||||||||||||||||||
proceeds from sales of real estate, net of debt assumed by buyers | 279,778,000 | 156,007,000 | 316,000,000 | 112,562,000 | 267,747,000 | ||||||||||||||||||||||||||||||
proceeds from paydown and maturity of securities | 1,740,000 | 14,847,000 | 10,329,000 | 16,709,000 | 21,159,000 | 29,609,000 | 30,850,000 | 31,321,000 | |||||||||||||||||||||||||||
proceeds from sale of investments in unconsolidated ventures | 1,779,000 | 140,146,000 | |||||||||||||||||||||||||||||||||
receipt (return) of borrower escrow deposits | |||||||||||||||||||||||||||||||||||
net (payments) receipts on settlement of derivative instruments | -18,811,000 | ||||||||||||||||||||||||||||||||||
reissuance of preferred stock to an equity method investee | |||||||||||||||||||||||||||||||||||
acquisition of noncontrolling interests | |||||||||||||||||||||||||||||||||||
earnings from investments in unconsolidated ventures | -13,798,000 | -1,875,000 | -32,265,000 | -31,318,000 | -17,447,000 | -122,394,000 | -113,992,000 | ||||||||||||||||||||||||||||
return of capital from investments in unconsolidated ventures | 30,475,000 | 70,199,000 | 159,929,000 | ||||||||||||||||||||||||||||||||
cash and restricted cash assumed from consolidation of sponsored fund | |||||||||||||||||||||||||||||||||||
net payments on settlement of derivative instruments | 5,838,000 | 3,250,000 | |||||||||||||||||||||||||||||||||
settlement of call spread option | |||||||||||||||||||||||||||||||||||
increase in escrow deposits | |||||||||||||||||||||||||||||||||||
change in escrow deposits related to financing arrangements | |||||||||||||||||||||||||||||||||||
costs associated with contributions from noncontrolling interests | |||||||||||||||||||||||||||||||||||
impairment of real estate and management contract intangibles | 153,398,000 | ||||||||||||||||||||||||||||||||||
cash and restricted cash contributed to colony northstar credit | -141,153,000 | ||||||||||||||||||||||||||||||||||
proceeds from sale of investments in unconsolidated venture | 0 | ||||||||||||||||||||||||||||||||||
amortization of discount and net origination fees on purchased and originated loans | -4,517,000 | -18,290,000 | -14,070,000 | -18,182,000 | |||||||||||||||||||||||||||||||
net gain on remeasurement of net assets of consolidated investment entities | |||||||||||||||||||||||||||||||||||
foreign currency loss recognized on repayment of loans receivable | |||||||||||||||||||||||||||||||||||
increase in other assets, operating restricted cash and due from affiliates | |||||||||||||||||||||||||||||||||||
payment of merger-related liabilities, net of cash acquired | 0 | 0 | 0 | -44,437,000 | |||||||||||||||||||||||||||||||
proceeds from syndication of investment, net of cash deconsolidated | 21,600,000 | ||||||||||||||||||||||||||||||||||
internalization of manager, net of cash acquired | |||||||||||||||||||||||||||||||||||
acquisition of cpi, net of cash acquired | 0 | 0 | 0 | -35,711,000 | |||||||||||||||||||||||||||||||
acquisition of thl hotel portfolio, net of cash acquired | 0 | ||||||||||||||||||||||||||||||||||
increase in restricted cash related to investing activities | -140,435,000 | ||||||||||||||||||||||||||||||||||
increase in escrow deposits related to financing arrangements | 1,660,000 | ||||||||||||||||||||||||||||||||||
cash held by investment entities consolidated | |||||||||||||||||||||||||||||||||||
effect of exchange rates on cash and cash equivalents | 716,000 | 3,434,000 | 6,100,000 | 913,000 | |||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | 20,544,000 | 292,921,000 | -38,663,000 | 271,015,000 | |||||||||||||||||||||||||||||||
total cash and cash equivalents, beginning of period | 0 | 0 | 0 | 376,005,000 | |||||||||||||||||||||||||||||||
cash and cash equivalents included in assets held for sale | -14,913,000 | 5,373,000 | -13,810,000 | ||||||||||||||||||||||||||||||||
cash and cash equivalents, end of period | 43,894,000 | 278,008,000 | -33,290,000 | 633,210,000 | |||||||||||||||||||||||||||||||
accretion in excess of cash receipts on purchased credit impaired loan | |||||||||||||||||||||||||||||||||||
impairment loss | |||||||||||||||||||||||||||||||||||
payment on cash collateral on derivative | |||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||||||
increase in restricted cash related to operating activities | |||||||||||||||||||||||||||||||||||
increase in due from affiliates | -11,940,000 | -1,932,000 | -10,847,000 | ||||||||||||||||||||||||||||||||
increase in other assets | -21,230,000 | 33,224,000 | -51,072,000 | ||||||||||||||||||||||||||||||||
increase in accrued and other liabilities | |||||||||||||||||||||||||||||||||||
increase in due to affiliates | |||||||||||||||||||||||||||||||||||
distributions from investments in unconsolidated ventures | 65,086,000 | 74,423,000 | 26,664,000 | ||||||||||||||||||||||||||||||||
acquisition of loans receivable | 0 | ||||||||||||||||||||||||||||||||||
proceeds from sales of loans receivable | 0 | 80,836,000 | 34,000,000 | ||||||||||||||||||||||||||||||||
cash receipts in excess of accretion on purchased credit impaired loans | 50,495,000 | 25,226,000 | 75,156,000 | ||||||||||||||||||||||||||||||||
acquisition of real estate, related intangibles and leasing commission, and improvements of real estate | -402,465,000 | -616,582,000 | -175,197,000 | ||||||||||||||||||||||||||||||||
acquisition of securities | -9,676,000 | ||||||||||||||||||||||||||||||||||
proceeds from sales of securities | 1,949,000 | 0 | 24,788,000 | ||||||||||||||||||||||||||||||||
cash assumed from consolidation of sponsored fund | |||||||||||||||||||||||||||||||||||
distributions to noncontrolling interests | -253,936,000 | -97,778,000 | -278,162,000 | ||||||||||||||||||||||||||||||||
redemption of units in operating company | 0 | ||||||||||||||||||||||||||||||||||
supplemental disclosure of cash flow information: | |||||||||||||||||||||||||||||||||||
cash paid for interest | 131,888,000 | 114,832,000 | 88,029,000 | ||||||||||||||||||||||||||||||||
cash paid for income taxes | 15,230,000 | 20,268,000 | 1,249,000 | ||||||||||||||||||||||||||||||||
supplemental disclosure of noncash investing and financing activities: | |||||||||||||||||||||||||||||||||||
dividends and distributions payable | 155,000 | 11,492,000 | 175,498,000 | ||||||||||||||||||||||||||||||||
assets acquired in merger | -44,622,000 | -202,636,000 | 17,461,773,000 | ||||||||||||||||||||||||||||||||
liabilities assumed in merger | -23,431,000 | -93,651,000 | 11,416,937,000 | ||||||||||||||||||||||||||||||||
noncontrolling interests assumed in merger | -768,000 | -8,556,000 | 602,014,000 | ||||||||||||||||||||||||||||||||
common stock issued for acquisition of nsam and nrf | 0 | -7,870,000 | 5,718,004,000 | ||||||||||||||||||||||||||||||||
preferred stock issued for acquisition of nrf | 0 | 0 | 1,010,320,000 | ||||||||||||||||||||||||||||||||
debt assumed by buyer of real estate reported as discontinued operations | 0 | 0 | 1,258,558,000 | ||||||||||||||||||||||||||||||||
net assets acquired in cpi restructuring | 0 | ||||||||||||||||||||||||||||||||||
net assets acquired in thl hotel portfolio | |||||||||||||||||||||||||||||||||||
preferred stock redemption payable | |||||||||||||||||||||||||||||||||||
investment deposits applied to acquisition of loans receivable, real estate and cpi group | |||||||||||||||||||||||||||||||||||
share repurchase payable | 10,177,000 | ||||||||||||||||||||||||||||||||||
loan payoff and real estate sale proceeds held in escrow | -41,905,000 | 17,298,000 | 45,870,000 | ||||||||||||||||||||||||||||||||
net settlement of redemption and investment in equity method investee | |||||||||||||||||||||||||||||||||||
redemption of op units for common stock | 3,978,000 | 18,172,000 | 638,000 | ||||||||||||||||||||||||||||||||
proceeds from secured financing in other assets | |||||||||||||||||||||||||||||||||||
foreclosure of collateral assets underlying loans receivable | 5,641,000 | 768,000 | 8,167,000 | ||||||||||||||||||||||||||||||||
amounts payable relating to improvements in operating real estate | 3,222,000 | 1,565,000 | 246,000 | ||||||||||||||||||||||||||||||||
contributions receivable from noncontrolling interests | -6,766,000 | ||||||||||||||||||||||||||||||||||
exchange of note for class a common shares | |||||||||||||||||||||||||||||||||||
net assets of investment entity deconsolidated | |||||||||||||||||||||||||||||||||||
net assets of sponsored fund consolidated, net of cash assumed | |||||||||||||||||||||||||||||||||||
change in fair value of contingent consideration | -4,850,000 | -3,400,000 | |||||||||||||||||||||||||||||||||
gain on sales of real estate assets | -15,190,000 | -6,862,000 | |||||||||||||||||||||||||||||||||
increase in restricted cash | |||||||||||||||||||||||||||||||||||
decrease in accrued and other liabilities | -62,022,000 | -10,151,000 | |||||||||||||||||||||||||||||||||
proceeds from sales of real estate assets, net of debt assumed by buyer | 69,762,000 | 903,841,000 | |||||||||||||||||||||||||||||||||
proceeds from sale of investment in unconsolidated venture | |||||||||||||||||||||||||||||||||||
change in restricted cash | 22,011,000 | -1,548,000 | |||||||||||||||||||||||||||||||||
borrowings from mortgage and other secured debt | 2,152,569,000 | 501,890,000 | |||||||||||||||||||||||||||||||||
repayment of borrowings from mortgage and other secured debt | -1,987,969,000 | -577,568,000 | |||||||||||||||||||||||||||||||||
change in escrow deposits for financing arrangements | -742,000 | 6,828,000 | |||||||||||||||||||||||||||||||||
settlement of call spread options | 0 | 6,900,000 | |||||||||||||||||||||||||||||||||
payment of fees and expenses related to contributions from noncontrolling interests | 0 | -6,765,000 | |||||||||||||||||||||||||||||||||
investment deposits applied to acquisition of loans receivable, real estate and cpi | 0 | 66,020,000 | |||||||||||||||||||||||||||||||||
proceeds from redemption of preferred equity interest in an investee included in other receivable | |||||||||||||||||||||||||||||||||||
amounts payable relating to purchase of securities available for sale | |||||||||||||||||||||||||||||||||||
investments in purchased loans receivable | -538,136,000 | ||||||||||||||||||||||||||||||||||
proceeds from sale of investment | 239,081,000 | ||||||||||||||||||||||||||||||||||
repurchase of preferred stock | |||||||||||||||||||||||||||||||||||
net asset acquired in cpi restructuring | 232,181,000 | ||||||||||||||||||||||||||||||||||
redemption of op units for cash in accrued and other liabilities | 5,085,000 | ||||||||||||||||||||||||||||||||||
cash flows from operating activities: | |||||||||||||||||||||||||||||||||||
equity in (earnings) losses of unconsolidated ventures | |||||||||||||||||||||||||||||||||||
impairment on convertible debt | |||||||||||||||||||||||||||||||||||
allowance for uncollectible accounts | |||||||||||||||||||||||||||||||||||
amortization of deferred financing costs | |||||||||||||||||||||||||||||||||||
amortization of equity-based compensation | |||||||||||||||||||||||||||||||||||
unrealized (gain) loss on investments and other | |||||||||||||||||||||||||||||||||||
realized (gain) loss on investments and other | |||||||||||||||||||||||||||||||||||
deferred income tax | |||||||||||||||||||||||||||||||||||
other income | |||||||||||||||||||||||||||||||||||
distribution from unconsolidated ventures | |||||||||||||||||||||||||||||||||||
straight line rental expense | |||||||||||||||||||||||||||||||||||
change in assets and liabilities: | |||||||||||||||||||||||||||||||||||
restricted cash | |||||||||||||||||||||||||||||||||||
receivables | |||||||||||||||||||||||||||||||||||
other assets | |||||||||||||||||||||||||||||||||||
other liabilities | |||||||||||||||||||||||||||||||||||
accounts payable and accrued expenses | |||||||||||||||||||||||||||||||||||
commission payable | |||||||||||||||||||||||||||||||||||
cash flows from investing activities: | |||||||||||||||||||||||||||||||||||
acquisition of townsend | |||||||||||||||||||||||||||||||||||
investment in convertible debt | |||||||||||||||||||||||||||||||||||
investments in unconsolidated ventures | |||||||||||||||||||||||||||||||||||
settlement of acquisition of securities | |||||||||||||||||||||||||||||||||||
payment related to the sale of the island interest | |||||||||||||||||||||||||||||||||||
cash flows from financing activities: | |||||||||||||||||||||||||||||||||||
contribution from northstar realty | |||||||||||||||||||||||||||||||||||
borrowings from credit facility | |||||||||||||||||||||||||||||||||||
borrowings from term loan | |||||||||||||||||||||||||||||||||||
repayment of term loan | |||||||||||||||||||||||||||||||||||
repayment of credit facility | |||||||||||||||||||||||||||||||||||
payment of financing costs | |||||||||||||||||||||||||||||||||||
call spread premium | |||||||||||||||||||||||||||||||||||
repurchase of shares related to equity-based awards and tax withholding | |||||||||||||||||||||||||||||||||||
excess tax benefit from equity-based compensation | |||||||||||||||||||||||||||||||||||
dividends | |||||||||||||||||||||||||||||||||||
contributions from redeemable non-controlling interests | |||||||||||||||||||||||||||||||||||
distributions to redeemable non-controlling interests | |||||||||||||||||||||||||||||||||||
retirement of shares of common stock | |||||||||||||||||||||||||||||||||||
effect of foreign exchange rate changes on cash | |||||||||||||||||||||||||||||||||||
net increase in cash | |||||||||||||||||||||||||||||||||||
cash - beginning of period | |||||||||||||||||||||||||||||||||||
cash - end of period | |||||||||||||||||||||||||||||||||||
supplemental disclosure of non-cash investing and financing activities: | |||||||||||||||||||||||||||||||||||
note receivable from third party related to the sale of the island interest | |||||||||||||||||||||||||||||||||||
assumption of deferred tax liability | |||||||||||||||||||||||||||||||||||
reclassification related to measurement adjustments/other | |||||||||||||||||||||||||||||||||||
reallocation of non-controlling interests in the nsam op | |||||||||||||||||||||||||||||||||||
tax effect related to the vesting of equity-based awards | |||||||||||||||||||||||||||||||||||
issuance of common stock related to settlement of award | |||||||||||||||||||||||||||||||||||
allocation of redeemable non-controlling interests in townsend | |||||||||||||||||||||||||||||||||||
dividend payable related to rsus | |||||||||||||||||||||||||||||||||||
conversion of ltip units to common stock | |||||||||||||||||||||||||||||||||||
issuance of common stock related to transactions | |||||||||||||||||||||||||||||||||||
conversion of deferred ltip units to ltip units | |||||||||||||||||||||||||||||||||||
deemed capital contribution from northstar realty | |||||||||||||||||||||||||||||||||||
accrued transaction costs relating to investments in unconsolidated ventures | |||||||||||||||||||||||||||||||||||
equity incentive plan | |||||||||||||||||||||||||||||||||||
supplemental disclosures of cash flow information: | |||||||||||||||||||||||||||||||||||
payment of interest expense | |||||||||||||||||||||||||||||||||||
payment of income tax |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
